Login / Signup

Cystatin C and interleukin-6 for prognosticating patients with acute decompensation of cirrhosis.

Gaurav PadiaBhawana MahajanAjay KumarUjjwal SonikaAmol Sonyabapu DahaleSanjeev SachdevaAshok DalalRoshan George
Published in: JGH open : an open access journal of gastroenterology and hepatology (2021)
Serum CysC can predict the development of RD and ACLF in patients of cirrhosis with AD.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • patient reported outcomes